eGFR decrease during antiviral C therapy with first generation protease inhibitors: a clinical significance?

E-ISSN： 1478-3231|35|1|71-78

ISSN： 1478-3223

Source： LIVER INTERNATIONAL (ELECTRONIC), Vol.35, Iss.1, 2015-01, pp. : 71-78

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dermatitis induced by first‐generation hepatitis C virus protease inhibitors

BRITISH JOURNAL OF DERMATOLOGY, Vol. 173, Iss. 1, 2015-07 ,pp. : 311-312

John Wiley & Sons Inc

Access to resources Recommend Favorite

Direct costs of first‐generation protease inhibitors for the treatment of genotype 1 chronic hepatitis C viral infection

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. 12, 2015-12 ,pp. : 974-976

John Wiley & Sons Inc

Access to resources Recommend Favorite

Evaluation of creatinine, cystatin C and eGFR by different equations in professional cyclists during the Giro d'Italia 3-weeks stage race

By Colombini Alessandra Corsetti Roberto Graziani Rosa Lombardi Giovanni Lanteri Patrizia Banfi Giuseppe

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 72, Iss. 2, 2012-04 ,pp. : 114-120

Informa Healthcare

Access to resources Recommend Favorite

Liver stiffness decrease after effective antiviral therapy in patients with chronic hepatitis C: Longitudinal study using FibroScan

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 25, Iss. 5, 2010-05 ,pp. : 964-969

John Wiley & Sons Inc

Access to resources Recommend Favorite

Patients treated with first‐generation HCV protease inhibitors exhibit high ribavirin concentrations

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 5, 2015-05 ,pp. : 517-524

John Wiley & Sons Inc

Access to resources Recommend Favorite